Jia Jie Biomedical CoROCO:4109 +9.87%60 ROA % is 5.86% as of Dec. 2025, which is 1484% above its 10-year median of 0.37. GuruFocus rates ROCO:4109 with a GF Score™ of 60/100 and a GF Value™ of NT$16.91 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 1,986 Consumer Packaged Goods companies, Jia Jie Biomedical Co ranks worse than 52.62% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Jia Jie Biomedical Co's annualizedNet Income for the quarter that ended in Dec. 2025 was NT$109.3 Mil.
Jia Jie Biomedical Co's average Total Assets over the quarter that ended in Dec. 2025 was NT$1,864.2 Mil. Therefore, Jia Jie Biomedical Co's annualized ROA % for the quarter that ended in Dec. 2025 was 5.86%.
The historical rank and industry rank for Jia Jie Biomedical Co's ROA % or its related term are showing as below:
ROCO:4109'
s ROA % Range Over the Past 10 Years
Min: -15.64 Med: 0.37 Max: 14.6
Current: 2.82
During the past 13 years, Jia Jie Biomedical Co's highest ROA % was 14.60%. The lowest was -15.64%. And the median was 0.37%.
ROCO:4109's ROA % is ranked worse than 52.62% of 1986
companies
in the Consumer Packaged Goods industry
Industry Median: 3.24
vs ROCO:4109: 2.82
Jia Jie Biomedical Co (ROCO:4109) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Jia Jie Biomedical Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jia Jie Biomedical Co ROA % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Jia Jie Biomedical Co's ROA % distribution charts can be found below:
* The bar in red indicates where Jia Jie Biomedical Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Jia Jie Biomedical Co (ROCO:4109) has a ROA % of 5.86% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Jia Jie Biomedical Co and its competitors. This is 1484% above median its historical median of 0.37. According to the industry distribution chart, Jia Jie Biomedical Co ranks #1045 out of 1986 companies in the Consumer Packaged Goods industry, placing it in the top 52.6%.
Is Jia Jie Biomedical Co's ROA % too high?
Jia Jie Biomedical Co's current ROA % of 5.86% is 1484% above median its 10-year median of 0.37. The Consumer Packaged Goods industry median ROA % is 3.24. Jia Jie Biomedical Co's value of 5.86% is 80.9% above this industry median. Based on the distribution chart, Jia Jie Biomedical Co ranks #1045 out of 1986 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Jia Jie Biomedical Co has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jia Jie Biomedical Co's ROA % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Jia Jie Biomedical Co ranks #1045 out of 1986 companies for ROA %. This places Jia Jie Biomedical Co in the lower half of its industry. The industry median ROA % is 3.24. Jia Jie Biomedical Co's value of 5.86% is 80.9% above this benchmark. While the company's 10-year median is 0.37 vs. the industry median of 3.24, Jia Jie Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Consumer Packaged Goods company?
The median ROA % among Consumer Packaged Goods companies is 3.24, based on 1,986 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jia Jie Biomedical Co's current ROA % of 5.86% is 80.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Jia Jie Biomedical Co and its competitors. For the Consumer Packaged Goods industry, the median ROA % is 3.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jia Jie Biomedical Co's current ROA % is 5.86%, which is 1484% above median its own 10-year median of 0.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jia Jie Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Jia Jie Biomedical Co (ROCO:4109) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$16.91, compared to a current price of NT$12.80 — trading 24.3% below its estimated fair value. The current ROA % is 5.86%, which is 1484% above median its 10-year median of 0.37 and 80.9% above the Consumer Packaged Goods industry median of 3.24. Jia Jie Biomedical Co's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Jia Jie Biomedical Co (ROCO:4109), the current ROA % is 5.86% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jia Jie Biomedical Co (ROCO:4109) Overvalued in 2026?
Based on GuruFocus' analysis, Jia Jie Biomedical Co stock appears to be undervalued.
The current stock price of NT$12.80 is trading 24.3% below its estimated GF Value™ of NT$16.91.
GuruFocus considers Jia Jie Biomedical Co to be Modestly Undervalued.
Key valuation signals for ROCO:4109:
ROA %: 5.86% (1484% above median its 10-year median of 0.37)
GF Value™: NT$16.91 vs. price of NT$12.80 (24.3% below fair value)
Industry Position: 80.9% above the Consumer Packaged Goods median (#1045 of 1986)
No single metric tells the full story. See the ROCO:4109 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jia Jie Biomedical Co Ltd is a Taiwan-based company. The Company is engaged in the processing, sale, and trading of softshell turtle food, the Manufacture of Dairy Products, and miscellaneous food manufacturing (e.g., softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules). The company is also engaged in the import, export of the aforementioned products, the distribution, bidding, and quotation of aforementioned products for domestic and foreign manufacturers, Wholesale of Nonalcoholic Beverages, candy wholesale, baked food wholesale, supplementary food wholesale, cosmetics wholesale, and sports equipment wholesale.
60GF Score
Get the complete analysis for ROCO:4109
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4109 has been successfully added to your 
